Balancing risks with JAK inhibitors in RMDs after the ORAL Surveillance study
1 tracks • 0 plays • 0 favorites
Balancing risks with JAK inhibitors in RMDs after the ORAL Surveillance study
user4304645171849
0:0017:09
News
Episodes
1
Balancing risks with JAK inhibitors in RMDs after the ORAL Surveillance study
user4304645171849